StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$1.86−0.03 (-1.84%)

Close on Nov 13, 2026Market cap $84.38MP/E –Yield –

Genelux ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Genelux

Genelux has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genelux figures

See a number that looks wrong?